Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-26

Clinical Trial Update: Intralesional Vitamin D in Alopecia Areata [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating intralesional Vitamin D for alopecia areata is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Alexandria University | Conditions: Alopecia Areata | Phase 1, Phase 2 | Status: UNKNOWN